The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 12,890,622 | 151,833 | SH | SOLE | 0 | 0 | 0 | |||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 5,371,816 | 133,827 | SH | SOLE | 133,827 | 0 | 0 | |||
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | 3,696,931 | 2,981,396 | SH | SOLE | 2,981,396 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 4,298,680 | 316,312 | SH | SOLE | 0 | 0 | 0 | |||
| ARGENX SE | SPONSORED ADR | 04016X101 | 11,432,180 | 15,500 | SH | SOLE | 15,500 | 0 | 0 | |||
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | 3,460,659 | 135,182 | SH | SOLE | 0 | 0 | 0 | |||
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 1,271,000 | 100,000 | SH | SOLE | 0 | 0 | 0 | |||
| CELCUITY INC | COM | 15102K100 | 4,940,000 | 100,000 | SH | SOLE | 0 | 0 | 0 | |||
| CIDARA THERAPEUTICS INC | COM NEW | 171757206 | 11,586,960 | 121,000 | SH | SOLE | 121,000 | 0 | 0 | |||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | 4,918,750 | 125,000 | SH | SOLE | 0 | 0 | 0 | |||
| DISC MEDICINE INC | COM | 254604101 | 4,889,920 | 74,000 | SH | SOLE | 74,000 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 5,134,654 | 250,838 | SH | SOLE | 250,838 | 0 | 0 | |||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 14,408,587 | 1,011,839 | SH | SOLE | 1,011,839 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 1,157,650 | 845,000 | SH | SOLE | 845,000 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 47,004,864 | 326,400 | SH | SOLE | 326,400 | 0 | 0 | |||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 5,240,707 | 92,592 | SH | SOLE | 92,592 | 0 | 0 | |||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 9,096,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 7,643,447 | 104,262 | SH | SOLE | 104,262 | 0 | 0 | |||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 4,040,070 | 437,237 | SH | SOLE | 437,237 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 8,358,350 | 715,000 | SH | SOLE | 715,000 | 0 | 0 | |||
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 1,198,178 | 349,323 | SH | SOLE | 0 | 0 | 0 | |||
| PHARVARIS N V | COM | N69605108 | 8,617,256 | 345,381 | SH | SOLE | 345,381 | 0 | 0 | |||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 188,822,400 | 12,480,000 | SH | SOLE | 12,480,000 | 0 | 0 | |||
| UNIQURE NV | SHS | N90064101 | 4,377,750 | 75,000 | SH | SOLE | 0 | 0 | 0 | |||